MHI and AstraZeneca to screen samples for cardiovascular and diabetes genetic traits

May 13, 2015

The Montreal Heart Institute (MHI) today announced a collaboration with AstraZeneca, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes.

Read more

A new platform makes telemedicine even more accessible

February 16, 2015

Reacts, a company led by cardiologist/intensivist Dr. Yanick Beaulieu at the MHI, has produced an innovative platform for telehealth and other applications.

Read more